ConCallIQ
Go Pro
Home › Management Profiles › Subramanian Santhanam
S

Subramanian Santhanam

CFO, Aurobindo Pharma

1 company 1 earning tracked 2 quotes

Promise Delivery Record

📊
Scorecard building

ConCallIQ tracks whether management promises made on earnings calls are delivered. Data for Subramanian Santhanam is being built as historical quarters are processed. Check back next quarter.

Notable Quotes

We have achieved our highest-ever quarterly revenues, reaching INR 7,979 crores, with a remarkable growth both year-on-year and quarter-on-quarter.
Subramanian Santhanam · Aurobindo Pharma Q3 FY25
We are on track to achieve our EBITDA margin of 21%-22% for FY25. The next quarter is expected to be stronger, driven by increased transient sales, execution of strategic initiatives, and improved operational efficiencies.
Subramanian Santhanam · Aurobindo Pharma Q3 FY25

Earnings Appearances

Aurobindo Pharma · Q3 FY25
Read earnings analysis →